Clínica Médica

Revisão do estado da arte | Revascularização na doença arterial coronariana estável.

19 Jun, 2022 | 14:39h

Revascularization in stable coronary artery disease – The BMJ

---

Revisão sistemática | Inibidores da Janus quinase para o tratamento de COVID-19.

19 Jun, 2022 | 14:38h

Janus kinase inhibitors for the treatment of COVID‐19 – Cochrane Library

Resumo: Are systemic Janus kinase inhibitors an effective treatment for people with COVID-19? – Cochrane Library

---

[Preprint] Estudo randomizado | Ivermectina não beneficia pacientes com COVID-19 leve a moderada no ambiente ambulatorial.

19 Jun, 2022 | 14:36h

Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv

Comentário: Study finds no benefit to taking ivermectin for COVID-19 symptoms – Duke University

---

Breve resumo dos principais fatos atuais e recomendações | Linfadenopatia regional após vacinação contra COVID-19 em pacientes com ou sem suspeita de câncer de mama.

19 Jun, 2022 | 14:21h

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

---

Recomendação de consenso | Guia para realizar revisões de medicamentos em idosos com câncer.

19 Jun, 2022 | 14:12h

How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative – Journal of Geriatric Oncology

Conteúdo relacionado: Deprescribing in Palliative Cancer Care – Life

---

Estudo de coorte | Risco de longo prazo de overdose ou crise de saúde mental após redução de dose e opioides.

19 Jun, 2022 | 14:08h

Long-term Risk of Overdose or Mental Health Crisis After Opioid Dose Tapering – JAMA Network Open

Editorial: New Data on Opioid Dose Reduction—Implications for Patient Safety – JAMA Network Open

Comunicado de imprensa: Increased overdose and mental health risks persist two years after opioid dose reduction –  UC Davis Center for Healthcare Policy and Research

---

Estudo entre pacientes com apneia do sono mostrou que multimorbidades estevam presentes em 2/3 dos indivíduos no momento do diagnóstico.

19 Jun, 2022 | 14:01h

Multimorbidity and overall comorbidity of sleep apnoea: a Finnish nationwide study – ERJ Open Research

Comentário: Study Highlights Prevalence of OSA and Overall Burden of Comorbidities – AJMC

 

Comentário no Twitter

Two-thirds of individuals with sleep apnoea are multimorbid at diagnosis and one-third are heavily multimorbid. Dorsopathies, musculoskeletal diseases, hypertension and metabolic diseases are the most common comorbidities preceding sleep apnoea diagnosis. https://t.co/6MOud2ePbm pic.twitter.com/wyTukZAIxR

— ERS publications (@ERSpublications) June 7, 2022

 

---

Podcast | Dicas sobre doença da vesícula biliar.

19 Jun, 2022 | 14:00h

#340 Gallbladder Disease – The Curbsiders

---

Revisão sistemática | Recomendações de diretrizes de prática clínica de alta qualidade relacionadas ao processo de diálise inicial.

19 Jun, 2022 | 13:52h

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review – PLOS One

---

Revisão sistemática atualizada e metanálise de estudos clínicos e pré-clínicos | Efeito poupador de opioides dos canabinoides para analgesia.

19 Jun, 2022 | 13:49h

Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies – Neuropsychopharmacology

 

Comentário no Twitter

MA of RCTs: In patients with cancer pain no effect of cannabinoid administration on opioid dose was found (MD= −3.8 mg; −10.97 to 3.37) or % change in pain scores (MD=1.84; −2.05 to 5.72) https://t.co/tTckc0z8Oz pic.twitter.com/Gh7LvYRz0n

— PfOL (@psychopharmacol) May 20, 2022

 

---